Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84628909 | 8462890 | 9 | F | 2009 | 20160914 | 20120316 | 20160927 | EXP | US-SANOFI-AVENTIS-2012SA017173 | AVENTIS | 94.00 | YR | E | F | Y | 63.50000 | KG | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84628909 | 8462890 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | D | UNKNOWN | 20839 | 75 | MG | TABLET | QD | |||||
| 84628909 | 8462890 | 2 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | D | UNKNOWN | 20839 | 75 | MG | TABLET | QD | |||||
| 84628909 | 8462890 | 3 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | D | UNKNOWN | 20839 | 75 | MG | TABLET | QD | |||||
| 84628909 | 8462890 | 4 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | D | UNKNOWN | 20839 | 75 | MG | TABLET | QD | |||||
| 84628909 | 8462890 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | D | UNKNOWN | 0 | 325 | MG | QOD | ||||||
| 84628909 | 8462890 | 6 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | D | UNKNOWN | 0 | 81 | MG | QD | ||||||
| 84628909 | 8462890 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 80 | MG | TABLET | QD | |||||||
| 84628909 | 8462890 | 8 | C | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 84628909 | 8462890 | 9 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 84628909 | 8462890 | 10 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 84628909 | 8462890 | 11 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | BREAKFAST | 0 | 145 | MG | TABLET | QD | ||||||
| 84628909 | 8462890 | 12 | C | AVAPRO | IRBESARTAN | 1 | Oral | 0 | 150 | MG | TABLET | QD | |||||||
| 84628909 | 8462890 | 13 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | TABLET | ||||||||
| 84628909 | 8462890 | 14 | C | MORPHINE | MORPHINE | 1 | IV PUSH | 0 | 1 | MG | INJECTION | ||||||||
| 84628909 | 8462890 | 15 | C | RESTORIL | TEMAZEPAM | 1 | Oral | 0 | 15 | MG | CAPSULE | ||||||||
| 84628909 | 8462890 | 16 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 5/500 | 0 | 1 | DF | TABLET | |||||||
| 84628909 | 8462890 | 17 | C | HEPARIN | HEPARIN SODIUM | 1 | Subcutaneous | DOSE:5000 UNIT(S) | 0 | TID | |||||||||
| 84628909 | 8462890 | 18 | C | INSULIN LISPRO | INSULIN LISPRO | 1 | Subcutaneous | 2 TO 14 UNITS Q6H PRN | 0 | ||||||||||
| 84628909 | 8462890 | 19 | C | INSULIN LISPRO | INSULIN LISPRO | 1 | Subcutaneous | 0-14 UNIT, Q6H PRN | 0 | ||||||||||
| 84628909 | 8462890 | 20 | C | ATROPINE. | ATROPINE | 1 | 1 GTTS RIGHT EYE QHS | 0 | 1 | GTT | |||||||||
| 84628909 | 8462890 | 21 | C | XALATAN | LATANOPROST | 1 | 0.005%, BOTH EYES QHS | 0 | 1 | GTT | |||||||||
| 84628909 | 8462890 | 22 | C | PNEUMOVAX 23 | PNEUMOCOCCAL VACCINE, POLYVALENT 23 | 1 | 0.5 CC SQ AS ORDERED. | 0 | |||||||||||
| 84628909 | 8462890 | 23 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 1 % RIGTH EYE QHS | 0 | 1 | GTT | |||||||||
| 84628909 | 8462890 | 24 | C | NAPROSYN | NAPROXEN | 1 | Oral | 0 | 500 | MG | BID | ||||||||
| 84628909 | 8462890 | 25 | C | NITROGLYCERINE | NITROGLYCERIN | 1 | Sublingual | Q5MIN PRN | 0 | .4 | MG | ||||||||
| 84628909 | 8462890 | 26 | C | HALCION | TRIAZOLAM | 1 | Oral | QHS PRN | 0 | .25 | MG | ||||||||
| 84628909 | 8462890 | 27 | C | FUROSEMIDE. | FUROSEMIDE | 1 | IVP | 0 | 40 | MG | 1X | ||||||||
| 84628909 | 8462890 | 28 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Topical | LOTION; 1 APPLICATION | 0 | BID | |||||||||
| 84628909 | 8462890 | 29 | C | LUMIGAN | BIMATOPROST | 1 | OU QHS | 0 | 1 | GTT | |||||||||
| 84628909 | 8462890 | 30 | C | VITAMIN K | PHYTONADIONE | 1 | Subcutaneous | 0 | 10 | MG | QD | ||||||||
| 84628909 | 8462890 | 31 | C | TRICOR | FENOFIBRATE | 1 | 0 | ||||||||||||
| 84628909 | 8462890 | 32 | C | HUMALOG | INSULIN LISPRO | 1 | 0 | ||||||||||||
| 84628909 | 8462890 | 33 | C | SUCRALFATE. | SUCRALFATE | 1 | Oral | 0 | 1 | G | TID | ||||||||
| 84628909 | 8462890 | 34 | C | TRAVATAN | TRAVOPROST | 1 | 0 | EYE DROPS | |||||||||||
| 84628909 | 8462890 | 35 | C | PRED FORTE | PREDNISOLONE ACETATE | 1 | FORM: DROPS TO BOTH EYES | 0 | |||||||||||
| 84628909 | 8462890 | 36 | C | KLONOPIN | CLONAZEPAM | 1 | 0 | .25 | MG | ||||||||||
| 84628909 | 8462890 | 37 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 84628909 | 8462890 | 38 | C | TRILIPIX | FENOFIBRIC ACID | 1 | Oral | 0 | 135 | MG | TABLET | QD | |||||||
| 84628909 | 8462890 | 39 | C | RISEDRONATE | RISEDRONATE SODIUM | 1 | 0 | 150 | MG | /month | |||||||||
| 84628909 | 8462890 | 40 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Oral | 0 | 250 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 84628909 | 8462890 | 1 | Cerebrovascular accident |
| 84628909 | 8462890 | 2 | Hypertension |
| 84628909 | 8462890 | 3 | Prophylaxis |
| 84628909 | 8462890 | 4 | Transient ischaemic attack |
| 84628909 | 8462890 | 5 | Product used for unknown indication |
| 84628909 | 8462890 | 6 | Product used for unknown indication |
| 84628909 | 8462890 | 14 | Pain |
| 84628909 | 8462890 | 15 | Insomnia |
| 84628909 | 8462890 | 16 | Pain |
| 84628909 | 8462890 | 24 | Pain |
| 84628909 | 8462890 | 25 | Chest pain |
| 84628909 | 8462890 | 26 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 84628909 | 8462890 | OT |
| 84628909 | 8462890 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 84628909 | 8462890 | Death | |
| 84628909 | 8462890 | Gastrointestinal haemorrhage | |
| 84628909 | 8462890 | Haemorrhage | |
| 84628909 | 8462890 | Pain | |
| 84628909 | 8462890 | Ulcer haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 84628909 | 8462890 | 1 | 20000101 | 20101231 | 0 | |
| 84628909 | 8462890 | 2 | 20000101 | 20101231 | 0 | |
| 84628909 | 8462890 | 3 | 20000101 | 20101231 | 0 | |
| 84628909 | 8462890 | 4 | 20000101 | 20101231 | 0 | |
| 84628909 | 8462890 | 5 | 2000 | 20111103 | 0 | |
| 84628909 | 8462890 | 6 | 20111103 | 0 | ||
| 84628909 | 8462890 | 7 | 20080218 | 0 | ||
| 84628909 | 8462890 | 8 | 20080218 | 0 | ||
| 84628909 | 8462890 | 9 | 20080218 | 0 | ||
| 84628909 | 8462890 | 11 | 20080218 | 0 | ||
| 84628909 | 8462890 | 12 | 20080218 | 0 | ||
| 84628909 | 8462890 | 17 | 20080225 | 0 | ||
| 84628909 | 8462890 | 18 | 20080225 | 20080226 | 0 | |
| 84628909 | 8462890 | 19 | 20080226 | 0 | ||
| 84628909 | 8462890 | 20 | 20080224 | 0 | ||
| 84628909 | 8462890 | 21 | 20080225 | 0 | ||
| 84628909 | 8462890 | 22 | 20080225 | 0 | ||
| 84628909 | 8462890 | 23 | 20080224 | 0 | ||
| 84628909 | 8462890 | 24 | 20080224 | 0 | ||
| 84628909 | 8462890 | 25 | 20080224 | 0 | ||
| 84628909 | 8462890 | 26 | 20080224 | 0 | ||
| 84628909 | 8462890 | 27 | 20080226 | 20080227 | 0 | |
| 84628909 | 8462890 | 28 | 20080226 | 0 | ||
| 84628909 | 8462890 | 29 | 20080226 | 0 | ||
| 84628909 | 8462890 | 30 | 20080226 | 20080229 | 0 |